Although a 30.8% frequency of neuroendocrine carcinomas was detected in the histological type analysis, histological data regarding tumor morphology, mitotic index and Ki-67 expression were not available in the assessed registry bases, hindering tumor confirmation and reliable analyses when comparing clinical outcomes between well- and poorly differentiated tumors. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.